Used as a research compound in the development of treatments for respiratory diseases, particularly as a selective inhibitor targeting specific ion channels involved in airway inflammation and constriction. Shows potential in reducing mucus hypersecretion and bronchoconstriction in preclinical models of asthma and chronic obstructive pulmonary disease (COPD). Investigated for its ability to modulate airway smooth muscle activity, making it a candidate for inhaled therapies aimed at improving lung function. Currently limited to laboratory and animal studies, with no approved clinical use as of now.